Comparison of Effectiveness and Safety for the Apixaban and Low-Molecular-Weight Heparin in Prevention of Deep Vein Thrombosis after Hip Replacement

被引：0
|
作者：
Wang, Lin [1 ]
Xie, Jia-bin [1 ]
Li, Qiu-wei [1 ]
机构：
[1] Wannan Med Coll, Yijishan Hosp, Dept Orthopaed, Western Zheshan Rd 2, Wuhu 241002, Anhui, Peoples R China
来源：
LATIN AMERICAN JOURNAL OF PHARMACY | 2021年 / 40卷 / 04期
关键词：
apixaban; deep venousthrombosis (DVT); low-molecular-weight heparin (LMWH); PROPHYLAXIS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The aim was to analyze the efficacy and safety of apixaban versus low-molecular-weight heparin (LMWH) for the prevention of deep venous thrombosis after the hip arthroplasty. Fifty patients with primary unilateral hip arthroplasty in The Yijishan Hospital of Wannan medical College between January 2020 and December 2020 were selected, which were randomly divided into apixaban group and low-molecular-weight heparin group. They were given drugs at 6 h after replacement, the patients in the apixaban group were given apixaban 5 mg/day with the course of 5 weeks; the another were given low-molecular-weight heparin 4 100 U/d with the course of 2 weeks. There were no significant differences between two groups (p > 0.05). The results indicate that full course of apixaban has clear effect and reliable security in the prevention of deep venous thrombosis after hip arthroplasty.
引用
收藏
页码：856 / 861
页数：6
相关论文
共 50 条
  • [41] A tale of two centers: Is low-molecular-weight heparin really superior for prevention of posttraumatic venous thromboembolism?
    Checchi, Kyle D.
    Costantini, Todd W.
    Badiee, Jayraan
    Berndtson, Allison E.
    Calvo, Richard Y.
    Rooney, Alexandra S.
    Wessels, Lyndsey E.
    Prieto, James M.
    Sise, C. Beth
    Sise, Michael J.
    Martin, Matthew J.
    Bansal, Vishal
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2021, 91 (03): : 537 - 541
  • [42] COMPARATIVE-STUDY ON THE ANTITHROMBOTIC EFFICACY OF HIRUDIN, HEPARIN AND A LOW-MOLECULAR-WEIGHT HEPARIN IN PREVENTING EXPERIMENTALLY-INDUCED VENOUS THROMBOSIS
    MONREAL, M
    GALEGO, G
    MONREAL, L
    ANGLES, AM
    MONASTERIO, J
    OLLER, B
    HAEMOSTASIS, 1993, 23 (03) : 179 - 183
  • [43] Efficacy and Safety of a DOAC Compared to Unfractionated Heparin and A Low Molecular Weight Heparin in the Prevention of Thromboembolism in Hematopoietic Stem Cell Transplant Recipients
    Azimi, Saeed
    Hajifathali, Abbas
    Parkhideh, Sayeh
    Salamzadeh, Jamshid
    Rahmati-Kamel, Bardia
    Dastan, Farzaneh
    Mehdizadeh, Mahshid
    Abiyarghamsari, Mahdiye
    Tavakoli-Ardakani, Maria
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01):
  • [44] Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study
    Lazo-Langner, A.
    Fleet, J. L.
    McArthur, E.
    Garg, A. X.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (10) : 1626 - 1635
  • [45] Preventive effects of low molecular weight heparin on formation of deep vein thrombosis by reducing D dimer values in patients undergoing spinal surgery
    Yin, X.
    Liu, P.
    Liu, B. -Y.
    Liu, Y. -Y.
    Fan, W. -L.
    Zhao, J. -H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (01) : 229 - 237
  • [46] Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
    Song, Yijun
    Yang, Dawei
    Hou, Dongni
    She, Jun
    Song, Yuanlin
    THROMBOSIS JOURNAL, 2023, 21 (01)
  • [47] Comparison between low molecular weight heparin and apixaban (direct oral anticoagulant) in the prophylaxis against venous thromboembolism after laparoscopic sleeve gastrectomy
    Abdelsalam, Ahmed
    Fikry, Michael
    Fahmy, Ahmed
    Hegazy, Tarek
    Hamdy, Afaf
    Refaat, Ahmed
    Elansary, Ahmed
    OBESITY SURGERY, 2025, 35 (03) : 934 - 940
  • [48] Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
    Coleman, Craig I.
    Caroti, Kimberly Snow
    Abdelgawwad, Khaled
    Psaroudakis, George
    Fatoba, Samuel
    Rivera, Marcela
    Schaefer, Bernhard
    Brobert, Gunnar
    Khorana, Alok A.
    Becattini, Cecilia
    Lee, Agnes Y. Y.
    Ekbom, Anders
    Carrier, Marc
    Brescia, Christopher
    Cohen, Alexander T.
    JACC: CARDIOONCOLOGY, 2023, 5 (02): : 189 - 200
  • [49] OUTPATIENT THROMBOSIS-PROPHYLAXIS DURING PLASTER-CAST IMMOBILIZATION OF THE LEG, USING LOW-MOLECULAR-WEIGHT HEPARIN
    KOCK, HJ
    SCHMITNEUERBURG, KP
    HANKE, J
    HAKMANN, A
    ALTHOFF, M
    RUDOFSKY, G
    HIRCHE, H
    CHIRURG, 1993, 64 (06): : 483 - 491
  • [50] The safety of low molecular-weight heparin after blunt liver and spleen injuries
    Rostas, Jack W.
    Manley, Justin
    Gonzalez, Richard P.
    Brevard, Sidney B.
    Ahmed, Naveed
    Frotan, Mohammad Amin
    Mitchell, Ellen
    Simmons, Jon D.
    AMERICAN JOURNAL OF SURGERY, 2015, 210 (01): : 31 - 34
12345